Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
SS-31 Elamipretide
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Longevity & Anti-Aging › SS-31 Elamipretide
← Back to catalog Longevity & Anti-AgingAvailable

SS-31 Elamipretide (10 mg)

MitochondriaATPCardioprotector
$135 USD10 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

Mitochondria-targeting peptide that binds to cardiolipin — stabilizes the inner membrane and restores ATP production in dysfunctional mitochondria.

  • Mechanism: Binds cardiolipin in the inner mitochondrial membrane and stabilizes energy production.
  • Evidence: Human trials (Phase 2/3) in mitochondrial myopathy and Barth syndrome, with mixed results.
  • In context: Some trials missed the primary endpoint; efficacy still uncertain.
Research range · SC
hasta 40 mg per application · once daily
🟢 Clinical evidence · Phase 3 trial dose

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundSS-31 Elamipretide
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaC32H49N9O5
Molecular weight639.8 g/mol
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

SS-31 (Elamipretide): research profile

SS-31, known in the clinical literature as elamipretide (also MTP-131 or Bendavia), is an aromatic-cationic tetrapeptide with the sequence D-Arg–Dmt–Lys–Phe-NH2, where Dmt is 2',6'-dimethyltyrosine, a non-natural amino acid. It was designed by Hazel Szeto and Peter Schiller in the early 2000s — hence “SS” — and has an unusual property: it crosses membranes and concentrates in the inner mitochondrial membrane independently of membrane potential.

There it binds cardiolipin, the phospholipid unique to that membrane that organizes the respiratory-chain complexes. In damaged mitochondria cardiolipin becomes oxidized and cytochrome c loses its anchor; SS-31 stabilizes the interaction, improves electron-transport efficiency, reduces reactive-oxygen-species production and increases ATP synthesis. It is, in essence, a structural stabilizer of the mitochondrion rather than a classic antioxidant.

Stealth BioTherapeutics' clinical development spanned Barth syndrome, primary mitochondrial myopathy, heart failure, dry macular degeneration and Leber hereditary optic neuropathy, with mixed results: several Phase 3 trials missed their primary endpoints. In September 2025 the FDA granted elamipretide (Forzinity) accelerated approval for Barth syndrome, an ultra-rare cardiolipin disorder. That approval belongs to the branded medicine; Renova's SS-31 is a research reagent.

SS-31 (Elamipretide) technical data

ClassMitochondria-targeting aromatic-cationic tetrapeptide (Szeto-Schiller peptide)
SequenceD-Arg–Dmt–Lys–Phe-NH2 (Dmt = 2',6'-dimethyltyrosine)
CAS736992-21-5
NamesElamipretide · MTP-131 · Bendavia · Forzinity (brand)
TargetCardiolipin in the inner mitochondrial membrane
Reported half-lifeA few hours in plasma; prolonged mitochondrial accumulation
Regulatory statusFDA accelerated approval for Barth syndrome (Sept 2025) as a branded medicine; Renova product is RUO

Questions about SS-31 (Elamipretide)

Are SS-31 and elamipretide the same compound?

Yes. SS-31 is the research name (after Szeto and Schiller, its designers); elamipretide is the international nonproprietary name it received on entering clinical trials, and MTP-131 or Bendavia are development names. All designate the same tetrapeptide.

How does SS-31 reach the mitochondrion?

Its alternating structure of aromatic and cationic residues lets it cross the plasma membrane and accumulate in the inner mitochondrial membrane without depending on membrane potential, which is unusual. Once there it binds cardiolipin, a phospholipid found only in that membrane.

What were elamipretide's clinical trial results?

Mixed. In primary mitochondrial myopathy, heart failure and dry macular degeneration several Phase 2/3 trials missed their primary endpoints. In Barth syndrome the initial crossover trial was negative but the open-label extension showed sustained improvement, and in September 2025 the FDA granted accelerated approval for that ultra-rare indication.

How does SS-31 relate to MOTS-c?

Both act on the mitochondrion, but differently: MOTS-c is a signal encoded by the mitochondrion itself that activates AMPK; SS-31 is a synthetic peptide that physically stabilizes the inner membrane through cardiolipin. They are investigated separately.

Related reading: SS-31 (Elamipretide): The Mitochondria-Targeting Peptide · MOTS-c: The Mitochondrial Peptide Explained

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty